Amesite Inc. (NASDAQ:AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announces today the demonstration of AI generated content with AI narration capabilities on its recently launched Version 6.0 platform, complementing its recent GPT-4 integration. The capabilities, demonstrated in Amesite’s free-to-the-public course on ChatGPT, demonstrate how content can be created with high efficiency and scalability, along with purpose-built, AI-driven features to support user learning.
Aytu BioPharma Announces Submission Of Cotempla XR-ODT Manufacturing Site Transfer Prior Approval Supplement
Company Expects a Six-Month Review of the Prior Approval Supplement Submission by the U.S. Food & Drug Administration Which, if Approved, Enables the Transfer of Cotempla Production to Contract Manufacturer
Upon
